The bitcoin of Biotech is about to go down

Penjualan

CRISPR Therapeutics AG (NASDAQ:CRSP)

Diupdate

NASDAQ:CRSP CRISPR Therapeutics AG

I view CRSP as one of the most interesting biotechnology stocks out there. DYOR. If it works, it will be huge. I am happy to see there will be opportunities to accumulate some stock, after I short it into my ideal entry levels.

Komentar:

approaching target 1

Komentar:

CRSP is in long term accumulation zone. It's a buy anywhere between 32 - 24 as a long term hold.

Komentar:

This trade did extremely well from an execution standpoint. The technicals are now indicating to me that price may reach close to $200 per share in the next year or two. This stock has all the signs of being a superior long term hold.

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.